Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
IDYA
IDYA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IDYA News
IDEAYA Initiates Phase 1 Trial for IDE892
1d ago
PRnewswire
Biocytogen and IDEAYA Advance New Drug Clinical Trial
Feb 28 2026
Newsfilter
IDEAYA Grants 346,200 Stock Options to New Employees
Feb 27 2026
PRnewswire
IDEAYA Grants 346,200 Stock Options to New Employees
Feb 27 2026
Newsfilter
IDEAYA Biosciences Initiates Phase 1 Trial for IDE034
Feb 25 2026
PRnewswire
IDEAYA Initiates Phase 1 Trial for IDE034
Feb 25 2026
Newsfilter
IDEAYA Appoints New Chief Development Officer
Feb 23 2026
PRnewswire
IDEAYA Appoints New Chief Development Officer
Feb 23 2026
Newsfilter
IDEAYA Biosciences Q4 Earnings Beat Expectations
Feb 17 2026
seekingalpha
IDEAYA Biosciences Provides 2025 Financial Update
Feb 17 2026
PRnewswire
IDEAYA Biosciences to Participate in Investor Events
Feb 02 2026
PRnewswire
IDEAYA Biosciences to Participate in Investor Events
Feb 02 2026
Newsfilter
IDEAYA Grants 44,200 Stock Options to New Employee
Jan 30 2026
PRnewswire
IDEAYA Grants 44,200 Stock Options to New Employee
Jan 30 2026
Newsfilter
IDEAYA Biosciences Updates 2026 Corporate Objectives at J.P. Morgan Conference
Jan 11 2026
PRnewswire
IDEAYA Biosciences Updates 2026 Strategic Objectives, Plans to Advance Four Registrational Trials
Jan 11 2026
Newsfilter
Show More News
